Newport Beach, California – May 15, 2026 – Lionheart Health http://www.LionheartLongevity.com announced today that it is preparing to begin patient enrollment in a new outside-the-United States (OUS) pilot study evaluating the company’s updated ImplantStim™ bioelectric dental implant regeneration platform.
ImplantStim™ is being developed to support faster dental implant integration, improved bone healing, enhanced tissue regeneration, and stronger implant stabilization through targeted bioelectric stimulation combined with regenerative signaling technologies.
The upcoming pilot study will evaluate an updated ImplantStim™ system design intended to further optimize localized regenerative signaling around dental implants and surrounding bone tissue. The next-generation platform incorporates refinements in stimulation delivery, implant architecture, and regenerative support technologies designed to enhance osseointegration and healing response.
Lionheart Health stated that its earlier pilot experience using the original ImplantStim™ technology in seven patients demonstrated dramatic reductions in healing and integration times compared to control patients receiving conventional dental implant approaches. According to the company, no adverse events related to the ImplantStim™ technology were observed during the pilot experience.
“We believe ImplantStim™ has the potential to redefine how dental implants heal and integrate,” said entity[“people”,”Howard Leonhardt”,”Founder and Executive Chairman of Lionheart Health”]. “Our goal is to reduce healing times, improve implant success rates, and support more rapid restoration of oral function through targeted bioelectric regenerative signaling.”
The new OUS pilot study is expected to evaluate multiple endpoints including:
- Time to implant stability
- Bone integration and osseointegration quality
- Healing response around the implant site
- Patient comfort and recovery metrics
- Safety and tolerability
- Implant retention and functional performance
ImplantStim™ is part of Lionheart Health’s broader platform of bioelectric stimulation technologies focused on regeneration, longevity, aesthetics, musculoskeletal repair, and performance enhancement. The company’s technology platform is designed around targeted bioelectric protein expression and regenerative signaling pathways intended to support tissue repair and functional recovery.
The company noted that the updated ImplantStim™ system was intentionally redesigned with a distinct next-generation architecture focused on optimizing regenerative performance while differentiating the platform from traditional dental implant systems currently on the market.
Lionheart Health plans to release additional details regarding study sites, enrollment timelines, and collaborating clinicians following final regulatory and operational preparations.
About ImplantStim™
ImplantStim™ is an investigational bioelectric dental implant regeneration platform under development by Lionheart Health. The technology is designed to support faster integration of dental implants into surrounding bone and soft tissue using targeted electrical stimulation and regenerative optimization technologies.
About Lionheart Health
Forward-Looking Statements
This press release contains forward-looking statements regarding future development activities, clinical studies, regulatory plans, commercialization potential, and anticipated performance of ImplantStim™ technologies. Actual results may differ materially from those expressed or implied. ImplantStim™ is currently investigational and has not been cleared or approved for commercial medical use in the United States.